Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Minority Investor?

<< Previous

Bullboard Posts

Next >>

Comment by Buckhenryon Apr 28, 2023 4:30pm

150 Views

Post# 35420038

RE:RE:Minority Investor?

While many say the sp does not matter.. I believe it does.. if it continues to go up and get over 5 bucks that will cause more institutional investors to get in making the price go up even more... then this puts pressure on the potential buyers.... course everything hinges on good data....that is my "optimistic" view point.

<< Previous

Bullboard Posts

Next >>

They started in video game investing, now they serve high net worth traders